Anti-Xa Activity of Enoxaparin for Prevention of Venous Thromboembolism in Severe Nephrotic Syndrome.
Status:
Terminated
Trial end date:
2018-11-30
Target enrollment:
Participant gender:
Summary
The primary objective is to test the hypothesis that enoxaparin efficacy is reduced in severe
nephrotic syndrome. Another purpose is to compare two dosing regimens.